University of Colorado Boulder 1002176641

RetroNectin® Recombinant Human Fibronectin Fragment

On August 14, 2025, the University of Colorado Boulder issued a contract award to Takara Bio USA Inc for 4 units of RetroNectin® Recombinant Human Fibronectin Fragment at a total obligated amount of $3,429.12. The procurement was likely for research purposes, with no specific contract end date indicated. The university, a public college or university under the Colorado hierarchy, is the buyer, and Takara Bio USA Inc is the recipient. The purchase was made in Boulder, Colorado, USA, and the award is categorized as a higher education procurement.

Description

RetroNectin® Recombinant Human Fibronectin Fragment